N-Methyl Zonisamide | CAS 68292-02-4 - Request Quote
N-Methyl Zonisamide
| SZ CAT No: | SZ-Z008005 |
| CAS No | 68292-02-4 |
| Mol.F. | C9H10N2O3S |
| Mol.Wt. |
226.3 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Hazard Statement:
Usage Note:
N-Methyl Zonisamide is chemically 1-(Benzo[d]isoxazol-3-yl)-N-methylmethanesulfonamide. N-Methyl Zonisamide is supplied with detailed characterization data compliant with regulatory guideline. N-Methyl Zonisamide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Zonisamide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 68292-02-4
Purchase 68292-02-4
Order 68292-02-4
Enquire 68292-02-4
price of 68292-02-4
68292-02-4 Supplier
68292-02-4 Manufacturer
68292-02-4 Exporter
buy high quality N-Methyl Zonisamide
Purchase N-Methyl Zonisamide
N-Methyl Zonisamide suppliers
N-Methyl Zonisamide manufacturers
N-Methyl Zonisamide price
Order N-Methyl Zonisamide
Enquire N-Methyl Zonisamide
N-Methyl Zonisamide cost
N-Methyl Zonisamide Supplier
N-Methyl Zonisamide Distributor
N-Methyl Zonisamide for Method Validation
Zonisamide Reference Standard
N-Methyl Zonisamide for ANDA Filing
N-Methyl Zonisamide for Forced Degradation Studies
N-Methyl Zonisamide Identification Standards
N-Methyl Zonisamide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.